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Research Advisor:  Professor Jeffrey Millman 
 
 
Induced pluripotent stem cells (iPSCs) can be differentiated into any cell type found in the body. The 
derivation of a stem cell derived β cell (SC-β) capable of responding to glucose by secreting insulin 
was hugely significant for diabetes research and opened up the possibility of cell replacement therapy 
to combat this widespread disease (Pagliuca et al. 2014). The optimization of differentiation 
procedures such as this could improve yield, function, cost, and efficiency of a stem cell-derived 
product. Current approaches to improve differentiation are primarily focused on signal transduction 
pathways, while the metabolic state of the cells has received little attention. Using a Seahorse XF24 
extracellular flux analyzer, we found that iPSCs have heavy reliance on fatty acid oxidation (FAO), a 
trait not shared by many mature cell types. Manipulation of stem cells and their mitochondrial 
oxidation by manipulating cell culture composition or adding small molecules BPTES, etomoxir, and 
UK5099 was shown to be possible in both suspension and adherent differentiations. Expression of 
key mitochondrial genes changed drastically during differentiation of iPSCs to SC-β cells. Thus, this 
body of work has demonstrated the importance of and paved the way for future research on the 
importance of mitochondrial oxidation to differentiation. 
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Chapter 1 
 
Introduction and Background 
 
1.1 An Overview of Induced Pluripotent Stem Cell 
Differentiation 
 
 
In 2007, the Yamanaka group generated induced pluripotent stem cells (iPSCs) from a human dermal 
fibroblast line; the iPSCs are capable of self-renewal and differentiating into a variety of cell types, and 
in addition share most morphological traits and behaviors of embryonic stem cells (ESCs). This 
landmark discovery has since prompted an influx of research on the characteristics and differentiation 
potential of iPSCs, as it offers a way to derive patient-specific cells of any type at high volumes from 
an easily obtainable tissue sample that can then be used for cell therapy (Takahashi et al. 2007). 
1.1.1 Stem Cell Pluripotency and Differentiation 
iPSCs and ESCs share many characteristics, pluripotency being the most critical to their use in 
medicine. Both types of  stem cell are capable of  converting to many somatic cell types through the 
process of  differentiation. Notably, some iPSCs have slightly reduced pluripotency (Stadtfelt et al. 
2010), but both murine iPSCs and ESCs are capable of  generating viable mice progeny through 
tetraploid complementation, demonstrating their potential to develop into any somatic cell type 
(Zhao et al. 2009). For ethical reasons, pluripotency tests akin to these cannot be conducted within 
human iPSCs, but it is possible that they are similarly pluripotent. Through differentiation of  
pluripotent stem cells, large quantities of  specific cell types can be generated and implanted back 
into a patient suffering from a disease, and in the future could be used to grow whole replacement 
organs. 
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Thus, a vital aspect of  using stem cells for cell therapy is the optimization of  this differentiation. 
Differentiation can be costly, plagued with cell death and lack of  efficiency, and take extensive 
culture time to complete. Optimizing the process to reduce these issues is essential for the transition 
of  stem cells from research subject to plausible, available medical therapy. Differentiation is often 
altered by changing factors and their concentrations, the duration spent in certain differentiation 
steps, alteration of  cell cluster sizes, or oxygen availability; however, even the best modern 
differentiations have much room for improvement. As an example, even in a well characterized 
cardiac differentiation that has been partially optimized by research groups, generation of  the 
desired cell type can take over a week, is affordable but still costly, and results in 64-89% of  cells 
expressing appropriate cell markers (Burridge et al. 2011). Cardiac differentiation has existed for 
years and still struggles with these issues; other differentiations are relatively new, and researchers 
hope to similarly optimize them. 
1.1.2 Diabetes and the Stem Cell-Derived β-Cell 
A recent and significant advancement in the field of  stem cells and differentiation is the derivation 
of  stem cell-derived β-cells (SC-β), pancreatic cells that release insulin in response to a glucose 
challenge, which was only accomplished in 2014 (Pagliuca et al. 2014). These cells have great 
potential for cell therapy, as 29.1 million people in the United States alone suffer from diabetes 
(“CDC 2014 Diabetes Report” 2014), a disease where pancreatic β-cells either die or become 
nonfunctional, causing high blood glucose levels in the body. Aside from diabetes’ immediate 
medical health issues, which include potentially fatal hyperglycemia, ketoacidosis, and coma, the 
disease can even be correlated with other health issues, like retinal or neurologic disorders (Diabetes 
Control and Complications Trial Research Groupa 1994). Replacement of  nonfunctional β cells by 
implantation with alternative cells could solve this modern health crisis; one option for replacement 
is SC-β cells, which are patient-specific, can be generated in large quantities, and can be tested for 
functionality (ability to release insulin in response to a glucose challenge) prior to implantation. 
Therefore, it is vital that the differentiation of  β-cells be optimized. Though altering factors, timing, 
and oxygen availability are all important to differentiation optimization, this research will explore 
characterization of  stem cells, the starting block of  any differentiation, and the possible influence of  
shifts in mitochondrial metabolism and its oxidation of  certain metabolites.  
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1.1.3 Mitochondrial Metabolism and Differentiation 
One distinct characteristic of  human embryonic stem cells (hESCs) that differs from mature cells is 
their metabolism: they are heavily reliant on glycolysis, an anaerobic process that generates ATP 
using glucose, to generate their energy. Accordingly, their mitochondria differ from other cell types: 
hESCs possess scarce mitochondria that are localized to the edges of  the cell, are underdeveloped 
with poor cristae formation, and appear to have restricted oxidative capacity (Varum et al. 2011). As 
hESCs differentiate, their mitochondrial networks increase in mass, branch out, and localize to other 
areas of  the cell (St. John et al. 2005), and their mitochondria become more active as oxidative 
phosphorylation (OXPHOS) becomes the primary source of  energy (Cho et al. 2006). Despite 
iPSCs being generated from adult cells with developed mitochondria and a reliance on OXPHOS, 
they seem to revert to a state similar to hESCs in terms of  metabolism and mitochondria (Prigione 
et al. 2010) and, upon differentiation, share similar mitochondrial regulation mechanisms as hESCs 
(Armstrong et al. 2010, Varum et al. 2011). It has been shown that altering hESC mitochondrial 
biogenesis can influence commitment to a germ layer in differentiation (Prowse et al. 2012). 
Thus, it has been acknowledged that certain mitochondrial behavior is related to stem cell identity 
and changes upon differentiation, but it is still debated as to whether this is a result of  
differentiation or a mediator of  it (Rehman et al. 2010), and the exact method to influence the 
mitochondria in a beneficial way is unknown, aside from attempting to increase the mitochondrial 
mass in some mature cell types and the application of  specific metabolites. 
At the forefront of  research on the topic of  stem cell differentiation, application of  specific 
metabolites and level of  saturation of  these metabolites have arisen as a way to influence 
differentiation (Yanes et al. 2010), and it is known that different media formulations can impact 
differentiation efficiency in hESC cultures transitioning to hematopoietic and neural cell types (Lee 
et al. 2015). Differences in iPSC and hESC behavior, as well as some of  the effects of  
reprogramming a fibroblast into an iPSC, have been attributed to metabolome differences related to 
mitochondrial metabolism and levels of  specific fatty acids (Panopoulos et al. 2012). Alteration of  
methionine metabolism has been shown to reduce stem cell pluripotency, and initiated unspecific 
differentiation (Shiraki et al. 2014). 
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Thus, recent literature has repeatedly been directed towards the subject of  metabolites and their 
influence upon stem cell metabolism and differentiation potential, but the exact connection between 
metabolites and differentiation has not yet been elucidated. If  the mechanisms underlying 
mitochondrial behavior that regulates differentiation exists and can be identified, optimization of  
differentiation through influencing the mitochondria may be possible. 
1.2 OXPHOS and Mitochondrial Metabolism 
Mitochondria are organelles that serve many essential functions within the cell: the generation of  
ATP for energy through OXPHOS, the mediation of  apoptosis (Wang 2001) and the regulation of  
potentially cytotoxic reactive oxygen species (ROS), and more (Marchi et al. 2011).  Manipulation of  
the mitochondria, and possible control of  differentiation through the mitochondria, requires 
understanding of  its function. 
1.2.1 Mitochondrial Structure and Function 
Mitochondria are organelles possessing two membranes, an inner and an outer membrane, and thus 
have two internal compartments: the matrix, which exists inside of  the inner membrane, and the 
intermembrane space. The outer membrane is dense with transport proteins and thus is somewhat 
permeable, allowing a broad set of  small molecules from the cytosol to filter into the intermembrane 
space. In contrast, the inner membrane is more impermeable, though it also contains transport 
proteins, and has invaginations called cristae that increase its area to facilitate exchange of  molecules 
(Alberts et al. 2002). The mitochondria uptakes food molecules, such as pyruvate and fatty acids, 
which it then converts to acetyl CoA and passes into the citric acid cycle, which generates electrons. 
These electrons are used to fuel the electron transport chain, a series of  protein complexes that 
takes in oxygen and electrons to move hydrogen ions across the inner membrane and establish a 
proton gradient. This proton gradient can be used to power the protein complex of  ATP synthase, 
which uses the energy of  the proton motive force generated by the gradient to convert ADP to 
ATP. This ATP is then exported to the cytosol, where it can be utilized by the rest of  the cell as 
energy. Overall, one molecule of  glucose can generate approximately 30 molecules of  ATP, and this 
production requires consumption of  oxygen. This entire process is summarized in Figure 1.1. One 
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final thing to note is that the inner membrane is not completely impermeable to protons; some 
protons can pass through, consuming oxygen to do so, without interaction with ATP synthase or the 
electron transport chain. This is called proton leak (Jastroch et al. 2010).  
  
Figure 1.1  An Overview of  Mitochondrial Structure. This figure was taken directly from Alberts 
et al., 2002. Food molecules will often be referred to as “mitochondrial fuels.” 
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1.2.2 Generation of  Pyruvate Through Glycolysis 
Pyruvate, one of  the food molecules commonly taken up by the mitochondria, is generated primarily 
through the process of  glycolysis, an aerobic process which occurs in the cytosol. Glycolysis is a 
reaction chain that consumes a glucose molecule and NAD+ to produce a net output of  two 
pyruvate, two ATP molecules, and the electron carrier NADH. Pyruvate will then often be shuttled 
into the mitochondria to be used in OXPHOS, but it can also undergo the process of  fermentation, 
which in human beings generates lactic acid and NAD+, which must be replenished if  glycolysis is to 
occur (Alberts et al. 2002). This process is summarized in Figure 1.2. 
  
Figure 1.2  An Overview of  Glycolysis. This figure was taken directly from Alberts et al., 2002. 
Comparatively, glycolysis produces less ATP than OXPHOS. It is also important to note that 
glycolysis is an anaerobic process, while mitochondrial OXPHOS requires oxygen for the electron 
transport chain’s function. Thus, in a hypoxic environment, cells will upregulate glycolysis enzymes 
and shift to glycolysis for ATP production (Robin et al. 1984), and in addition will regulate 
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OXPHOS (Taylor 2008). Shifts similar to this are not limited to solely hypoxic environments—cell 
types utilize glycolysis to different degrees. The upregulation of  glycolysis and role as the primary 
generator of  ATP is well documented in both cancer cells (Ganapathy-Kanniappan et al. 2013) and 
stem cells, which are known to have increased glycolysis and decreased but still present OXPHOS 
(Ito et al. 2014). 
1.2.3 Healthy Mitochondrial Function Is Essential to β-Cell Function 
Having outlined the processes of  glycolysis and OXPHOS, and having described the mitochondria, 
it is now possible to understand how essential healthy mitochondrial function is to the function of  a 
β-cell. Figure 1.3 gives a simple overview of  how glucose stimulates insulin release. The process of  
insulin release as a response to glucose moves directly through the mitochondria, and relies on the 
mitochondria to process pyruvate and produce ATP. Once ATP has been produced, it inhibits the 
outward flow of  potassium by blocking potassium channels and depolarizes the cell, causing an 
inward flow of  calcium that then stimulates insulin granule exocytosis. Without proper functioning 
of  the mitochondria, insulin release can be disrupted. 
 
Figure 1.3  An Outline of  Insulin Release Due to Glucose Uptake. This figure was taken 
directly from Maechler and Wollheim’s 2001 article. 
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The disruption of  insulin release due to an error in this process can lead to diabetes. Notably, 
mutations in mitochondrial DNA (mitochondria have their own set of  DNA, separate from the 
nucleus of  the cell they reside in) can initiate diabetes, with no other known mutation (Sivitz and 
Yorek 2010). This implies that a disruption in solely mitochondrial function is enough to cause 
diabetes, highlighting the importance of  healthy mitochondria to β-cell function. 
1.2.4 Mitochondrial Properties Essential to this Work 
Fully exploring all mitochondrial structures and functions in detail would be impossible, but there 
are several key properties that are relevant to this work. 
Many food molecules serve as fuel for the citric acid cycle, some of  the most prominent being 
pyruvate, fatty acids, and amino-acids. This work will focus upon pyruvate oxidation, fatty acid 
oxidation (FAO), and glutamine oxidation, the amino acid that literature suggests is indispensable for 
stem cells (Tohyama et al. 2016).  
Pyruvate and fatty acids are both converted into acetyl-CoA upon entering the mitochondrial matrix, 
which can be input into the citric acid cycle. Glutamine is converted to glutamate (catalyzed by the 
enzyme glutaminase) and then α-ketoglutarate, which is also a substrate in the citric acid cycle. 
Pyruvate and fatty acids are both moved into the mitochondrial matrix by transport proteins on the 
inner membrane: mitochondrial pyruvate transporters MPC1 and MPC2, and carnitine 
palmitoyltransferase I (CPT1) for long-chain fatty acids, among possible others. These transporters 
specifically can be inhibited by the small molecules UK5099 for the pyruvate transporters, and 
etomoxir for CPT1. Application of  these inhibitors prevents pyruvate oxidation or FAO. Glutamine 
oxidation can be inhibited by the application of  Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl 
sulfide (BPTES), which inhibits glutaminase, the enzyme that converts glutamine to glutamate. 
Other mitochondrial processes can also be inhibited or disrupted, including the action of  ATP 
synthase, certain complexes in the electron transport chain, and the proton gradient. Disruptions of  
these processes can reveal information about the mitochondria, and are implemented in this 
experimental work. 
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Oligomycin binds and inhibits ATP synthase, preventing the exchange of  protons across the 
gradient for conversion of  ADP to ATP. Antimycin A and rotenone disrupt and destroy the proton 
gradient, preventing any consumption of  oxygen by the electron transport chain and use of  the 
gradient by ATP synthase. Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) is an 
uncoupler, transporting protons across the inner cell membrane before they are used by ATP 
synthase, allowing for the continuous operation of  the electron transport chain, and maximal use of  
oxygen by the mitochondria. 
These chemicals and their effects can be seen summarized in Figure 1.4. These inhibitors and 
disrupted processes specifically will be utilized in this work. 
 
Figure 1.4  Inhibition and Disruption of  Mitochondrial Processes in this Research. All 
substances listed in red are inhibitors, and arrows demonstrate where they affect mitochondrial 
respiration. 
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Chapter 2 
 
Characterization of  Stem Cell Mitochondrial 
Metabolism 
 
2.1 Introduction 
 
Following the creation of human induced pluripotent stem cells (iPSCs) in 2007 (Yamanaka 2007), 
research has focused on the optimization of differentiation protocols to produce large quantities of 
mature, functional cells. Ideally, cells could be collected from a patient, converted to an iPSC, 
differentiated into mature cells, and implanted back into the patient. Current differentiation 
methodology is effective, but plagued with cell death, low efficiency, and extensive culture time; thus, 
optimizing these processes is necessary to move forward. Often, optimization involves altering media 
formulations, applied factors, the sizing of clusters, or the time duration of certain differentiation 
steps. As stem cells are the starting point of any differentiation, and cell loss often occurs early in the 
process, characterization of stem cell behavior and biology is imperative to improving differentiation. 
 
Human embryonic stem cells (hESCs) have been thoroughly studied in literature. As mentioned in 
chapter one, a distinct characteristic of hESCs that differs from mature cell types is their metabolism: 
they are heavily reliant on glycolysis, and according to some studies possess underdeveloped 
mitochondria (Varum et al. 2011). Despite iPSCs being generated from adult cells with developed 
mitochondria and a reliance on oxidative phosphorylation (OXPHOS), they appear to revert to a state 
similar to hESCs in terms of metabolism and mitochondria (Prigione et al. 2010). As they differentiate, 
stem cells grow to rely upon OXPHOS more than glycolysis, a shift possibly attributed to 
mitochondrial mass and network branching. 
 
Due to the heavy reliance on glycolysis to generate ATP within a stem cell and the clear shift to 
OXPHOS in mature cells, most literature on stem cells has focused on glycolysis, rather than the 
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mitochondria and OXPHOS. However, it has been shown that the mitochondria of stem cells are 
carefully regulated, and that mitochondrial behavior or the metabolites taken up by the cell, specifically 
fatty acids, could possibly affect differentiation (Alakpa et al. 2016). It has also been shown that 
increased glucose concentration can suppress murine ESC neural differentiation (Yang et al. 2016). 
This emerging evidence that metabolites and mitochondrial consumption of available fuels within 
stem cells has prompted our investigation into the mitochondrial oxidation of these fuels. As the 
Millman lab specializes in endodermal differentiation to a stem cell-derived β cell, we chose to study 
this differentiation process specifically. Thus, this body of work sought to characterize the 
mitochondrial behavior of stem cells and several other mature cell types related to the β cell. 
2.2 Abstract 
 
Most research on stem cells has stressed their metabolic dependence on glycolysis for energy 
production, emphasizing a decrease in mitochondrial oxidative activity in immature cells. However, 
mitochondrial oxidation still occurs and its use of energy sources could be cell type dependent. 
Through analysis with a Seahorse XF24 extracellular analyzer, we were capable of quantifying the ATP 
production, maximal respiration, and reliance of cells on specific fuel sources in terms of their oxygen 
consumption. We demonstrated that stem cell mitochondrial metabolism relied heavily on fatty acid 
oxidation (FAO) as opposed to pyruvate or glutamine oxidation. This was observed within HUES8, 
an hESC line, and two iPSC lines that were reprogrammed from 1016 fibroblasts, one line a clone of 
the other. Stem cells were also shown to have the largest capacity for FAO by using analysis of their 
maximal respiration. Combined, these two findings indicate that stem cells require mitochondrial 
FAO, though at this point we can only hypothesize as to why this may be. 
Comparatively, mature cell types such as fibroblasts and INS-1s were found to rely less upon FAO 
and fibroblasts had lower capacity for its use, indicating that they favored pyruvate or glutamine 
oxidation. Thus, we conclude that this reliance on FAO is characteristic of stem cells, and that shifts 
in oxidation pathway reliance may be linked to differentiation or cell identity. 
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2.3 Materials and Methods 
 
2.3.1 The Seahorse XF24 Extracellular Flux Analyzer 
To analyze mitochondrial OXPHOS, the Seahorse XF24 extracellular flux analyzer (henceforth 
referred to as the Seahorse) was implemented. The Seahorse is capable of measuring oxygen 
consumption rate (OCR) as well as rate of acid efflux (ECAR) in a 24 well plate. To quantify cellular 
respiration on a Seahorse, we injected solutions with oligomycin, FCCP, and then a solution of 
antimycin A and rotenone, which will be called a mitochondrial functionality test. The specific impact 
of each of these chemicals upon the mitochondria was detailed in Section 1.2.4, but is summarized in 
Table 2.1. We optimized concentrations of these chemicals for use with a 1016 SeVA stem cell line (a 
line used within Pagliuca et al. 2014 and Millman et al. 2016), an iPSC line reprogrammed from 1016 
fibroblasts. We kept the applied concentrations consistent through all Seahorse runs, with injections 
resulting in final concentrations of 3µM oligomycin, 0.25µM FCCP, 2µM antimycin A, and 1µM 
rotenone. 
Table 2.1 Mitochondrial Functionality Test Chemicals 
Term Function Final Concentration 
Oligomycin ATP synthase inhibitor 3 µM 
FCCP Mitochondrial uncoupler of ATP 
synthesis and the electron 
transport chain 
0.25 µM 
Antimycin A Binds cytochrome c reductase to 
inhibit electron transport, 
eliminating the proton gradient of 
the mitochondrial inner 
membrane (Ma 2012) 
2 µM 
Rotenone Inhibitor of the electron transport 
chain through mitochondrial 
complex I. 
1 µM 
 
Analysis of cell behavior following injection of these chemicals allows quantification of cell behavior. 
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A general overview of cell properties as related to Seahorse measurement and injections can be viewed 
in Figure 2.1, allowing quantification of mitochondrial baseline respiration, ATP production, maximal 
mitochondrial respiration, proton leak, and non-mitochondrial respiration. 
 
Figure 2.1  Seahorse XF24 Mitochondrial Functionality Test. A Seahorse mitochondrial 
functionality test involves injection of solutions with the chemicals oligomycin, FCCP, and 
antimycin A/rotenone to assess aspects of mitochondrial oxygen consumption.   
Each of  these mitochondrial properties and its definition as used in this body of  work can be seen in 
Table 2.2. 
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Table 2.2 Mitochondrial Functionality Test Terminology 
Term Definition Mathematical Definition 
Baseline The OCR of cells at a resting state. The average of data collected 
prior to any injection. 
ATP production The OCR used for production of 
ATP by mitochondrial ATP 
synthase. 
The difference between baseline 
and the average of data following 
the injection of oligomycin. 
Proton leak OCR related to protons crossing 
into the mitochondrial matrix 
without ATP synthase (Jastrovich 
2010). 
The difference between the 
average of data following the 
injection of oligomycin and the 
average of data following the 
injection of antimycin 
A/rotenone.  
Maximal Respiration The maximum OCR the cellular 
mitochondria are capable of 
consuming. 
The maximum OCR following 
injection of FCCP, with non-
mitochondrial respiration 
removed. 
Non-mitochondrial respiration OCR of processes occurring 
outside of the mitochondria. 
The average of data following the 
injection of antimycin 
A/rotenone. 
 
To allow for easily comprehensible data analysis, and to allow for simple comparison between 
Seahorse runs, the measured Seahorse OCR will be mathematically adjusted throughout this analysis. 
Two main adjustments will be performed: representing OCR as a fraction of ATP production, and 
representing OCR as a fraction of baseline. When representing OCR as a fraction of ATP production, 
the average baseline value is set to one, and the average value following oligomycin injection is set to 
zero. Similarly, when representing OCR as a fraction of baseline, the average baseline value is set to 
one, and the average value following antimycin A/rotenone injection is set to zero. Both eliminate 
non-mitochondrial respiration from the measurements. These two adjustments were performed upon 
Figure 2.1, and can be seen in Figure 2.2. 
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Figure 2.2  Seahorse XF24 Mitochondrial Test Mathematical Adjustments. A Seahorse 
mitochondrial functionality test with OCR values, adjusted to set either oligomycin injection at zero 
or the antimycin A injection to zero. 
 
2.3.2 Cell Culture in Preparation for a Seahorse Run 
To prepare for a Seahorse run, the selected cells were single-cell dispersed within an appropriate media 
for their respective line, and plated upon a Seahorse XF24 Cell Culture 24 well microplate coated with 
fibronectin. Four wells out of the twenty-four served as background wells, and were left with only a 
fibronectin coating and media. Cell lines were typically maintained for approximately 48 hours within 
the microplate, feeding stem cell lines every twenty-four hours. Upon reaching the desired cell 
confluency, the media was aspirated and replaced with 500 µL of RPMI 1640 (Sigma-Aldritch) 
medium containing 20mM glucose and 1mM sodium pyruvate (note that we altered this formulation 
within select later experiments, and INS-1 cells require a RPMI 1640 media at 2mM glucose). The 
microplate was then placed within a 37 ºC non-CO2 incubator for 90 minutes before testing using the 
Seahorse, to eliminate temperature variations. Meanwhile, a Seahorse sensor cartridge was prepared 
for solution injection, and placed within the 37 ºC non-CO2 incubator for at least 60 minutes before 
insertion into the Seahorse for calibration. Cell lines, appropriate media formulations for their culture, 
typical seeding densities, and ideal final confluency for a Seahorse run can be seen in Table 2.3. 
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Table 2.3 Culturing Cell Lines Within Seahorse XF24 Microplates. Abbreviations include 
Dulbecco’s modified Eagle’s medium (DMEM), FBS (fetal bovine serum), penicillin-streptomycin 
(P/S), and non-essential amino acids (NEAA). 
Cell Line Media Culture Duration within 
Microplate 
Seeding 
Density 
(cells/well) 
Ideal Final 
Confluency 
(%) 
1016 SeVA iPS (adherent) mTeSR1 48 hours 100,000 80-90 
1016 Fibroblast DMEM + 20% 
FBS + 1% 
P/S+1% 
NEAA +1% 
GlutaMax+ 
20mM glucose 
48 hours 50,000 100 
HUES8 embryonic stem 
cell (suspension) 
mTeSR1 48 hours 100,000 80-90 
C9 SeVA iPS (adherent) mTeSR1 48 hours 100,000 80-90 
INS-1 RPMI 1640 + 
10% FBS+ 1% 
P/S + 1% 
pyruvate 
48 hours 90,000 80-90 
 
2.3.3 Analysis of Specific Mitochondrial Oxidation Pathways with Seahorse 
In addition to the data provided by the mitochondrial functionality test, additional inhibitory small 
molecules can be injected to determine the reliance of the cells upon specific types of mitochondrial 
oxidation, such as pyruvate oxidation.  Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide 
(BPTES), etomoxir, and UK5099 were injected with the Seahorse prior to the mitochondrial 
functionality test injections. BPTES, etomoxir, and UK5099 inhibit glutamine oxidation, fatty acid 
oxidation (FAO), and pyruvate oxidation, respectively. When injected by the Seahorse, each results in 
a loss of OCR, corresponding to how much the cell was dependent on the related mitochondrial fuel 
source for oxidation and oxygen consumption. We will thus call this loss of respiration “dependence,” 
and its value in a variety of cell types can be compared.  
A summary of relevant information for each chemical is listed in Table 2.4. 
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Table 2.4 Small Molecules Impacting the Mitochondria 
 Final 
concentration 
Target of Inhibition Related method 
of OXPHOS 
BPTES 30 µM Glutaminase Glutamine 
oxidation 
Etomoxir 40 µM Carnitine palmitoyltransferase Fatty acid 
oxidation/β 
oxidation 
UK5099 4 µM Mitochondrial pyruvate 
carriers 
Pyruvate 
oxidation 
 
The effects of each of these chemicals was further characterized by calculating the concentration of 
NAD+ with an NAD+ kit (Cayman Chemical) following a 20 minute treatment with RPMI 1640, 
10mM pyruvate, and 20mM glucose as well as a small molecule with the concentration listed in Table 
2.4. There was an observed increase in NAD+ concentration following etomoxir and UK5099 
treatment. 
 
To efficiently compare different Seahorse runs and dependencies, data was mathematically adjusted 
to be a fraction of ATP production, as detailed in section 2.3.1. This allows each dependence to be 
represented as a fraction of total ATP production, which is comprehensible. 
 
The INS-1 cell line, a rat insulinoma line provided by the Urano lab at Washington University, varied 
drastically from other cell types in its behavior during a mitochondrial functionality test; this was likely 
due to its response to glucose. Thus, a Seahorse run with INS-1 cells was started with an RPMI 1640 
solution with 2 mM glucose and 1mM sodium pyruvate, with all following injections resulting in a 20 
mM glucose environment, and the first glucose injection being accompanied by one of the three small 
molecules mentioned above, at concentrations of 30 µM BPTES, 100 µM etomoxir, and 200 µM 
UK5099. 
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2.4  Results  
2.4.1 Stem Cells Rely Primarily on FAO 
 
To begin assessing the mitochondrial respiration of undifferentiated iPSCs, we measured total OCR 
and used injection of oligomycin, FCCP, antimycin A, and rotenone to understand what cellular 
processes contributed to OCR.  We measured that mitochondrial respiration was 1.48 +/- 0.412 
femtomole/minute/cell, maximal respiration was 2.82 +/- 0.36 femtomole/minute/cell, proton leak 
was 0.283 +/- 0.0768 femtomole/minute/cell, and non-mitochondrial respiration was 0.395 +/- 
0.113 femtomole/minute/cell. This data confirmed our assumption that the majority of OCR was 
due to mitochondrial respiration. To explore this further, we used injection of BEU to determine 
what fuels the undifferentiated iPSC were using for mitochondrial respiration. we found the cells 
primarily relied on fatty acids for OXPHOS. This was surprising because undifferentiated iPSCs 
generate a lot of pyruvate due to the high level of glycolysis and, though it has been hypothesized 
that the low level of activity still occurring within the mitochondria of a stem cell might serve to 
support lipogenesis (Zhang et al. 2016), the degree to which this occurs and its comparison to other 
types of mitochondrial oxidation has not been shown. 
 
Prior to a mitochondrial functionality test, the small molecules BPTES, etomoxir, and UK5099 were 
injected using the Seahorse onto 1016 SeVA iPSCs (Figure 2.3). Injection of etomoxir impacted 
FAO, and its addition to the cells prompted a loss of OCR. This loss accounted for nearly all the 
oxygen consumed by ATP production in the mitochondria, indicating that iPSCs rely heavily on 
FAO for oxygen consumption. 
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Figure 2.3  1016 SeVA iPSCs rely upon FAO over other fuel sources. A mitochondrial 
functionality test preceded by injection of a small molecule at the black arrow: BPTES, etomoxir, or 
UK5099. 
To confirm that this reliance upon FAO was not a property only of  1016 SeVA iPSCs, two other stem 
cell lines were analyzed. HUES8 cells obtained from the Melton laboratory at Harvard, which are 
hESCs, were also analyzed with the Seahorse after being in suspension culture. C9 iPS cells, which are 
clones of  the 1016 SeVA iPSC, were also tested and found to possess a similar mitochondrial 
dependence profile, with high FAO. All stem cell lines analyzed share a similarly large loss of  
respiration upon etomoxir injection, accounting for a large amount of  the oxygen consumption 
involved in ATP production (Figure 2.4). The cells analyzed were from both suspension and adherent 
cultures, so this loss of  respiration was not related to the cell culture system. 
It is important to note, when comparing dependencies of  cell types, that the fractional dependence 
of  each cell type adds up to over 1. This is not an error, although it implies that the total oxygen 
consumption of  each type of  mitochondrial oxidation adds up to more than the respiration consumed 
by ATP production, which should not be possible. In reality, the application of  each of  the small 
molecules can influence respiration generated by each of  the fuel sources studied. For example, 
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etomoxir’s inhibition of  fatty acid transport into the matrix of  the mitochondria prevents FAO, 
reduces input to the TCA cycle, and then limits output to the electron transport chain, which 
consumes oxygen. However, as pyruvate and glutamine oxidation also provide substrates to the TCA 
cycle, their products’ movement through the cycle and the following change in oxygen consumption 
are also impacted. Thus, the dependence of  the cell on each fuel source measured here is not exact; it 
still demonstrates that in stem cells FAO contributes the most to cellular respiration and ATP 
production. 
Additionally, it should be noted that HUES8 ES cells have a negative dependence upon glutamine 
oxidation. In these cells, the reaction to BPTES was for OCR to increase; possibly, this was due to 
some kind of  oxygen consumption compensation from other fuel types or the mitochondria. 
 
Figure 2.4  FAO reliance is characteristic of  stem cells. Bar graph comparison of  the dependence 
of  various stem cell lines upon different types of  mitochondrial oxidation. Dependence is defined as 
the loss of  OCR following injection of  a small molecule. 
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As a way to observe the effects of  the small molecules upon the 1016 SeVA iPSCs, and better 
characterize the effects of  the small molecules, the concentration of  NAD+ was quantified. BPTES 
saw a limited effect upon NAD+ concentration, while both etomoxir and UK5099 appeared to cause 
a mild increase in NAD+ concentration after 20 minutes of  exposure. This exposure time was chosen 
because it mimics the Seahorse timing, and a drop in oxygen consumption due to the small molecules 
occurs far before 20 minutes have passed. Hypothetically, as the TCA cycle slows less NAD+ 
consumption would occur, so it is plausible that there is an increased concentration of  NAD+ 
following application of  these small molecules. 
 
Figure 2.5 Application of  small molecules impacts NAD concentration minimally. Bar graph 
comparison of  the cellular NAD concentrations following application of  the small molecules for 
twenty minutes of  exposure. 
2.4.2 Other Cell Types Do Not Rely Heavily on FAO Like Stem 
Cells 
Having determined that stem cell lines are reliant on FAO, it is important to know if  this is a property 
inherent to stem cells, or if  it is seen in other cell types. We chose to study two cell types that are 
involved in the process of  taking a patient sample to a β cell: 1016 fibroblasts and stage 1 definitive 
endoderm (DE) cells, derived from iPSCs. The relationship between these cell types can be seen in 
Figure 2.6. 
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Figure 2.6  The protocol of  stem cell-derived β-cell differentiation. The general outline of  a SC-
β cell differentiation from a human embryonic stem cell, which will be elaborated on in Chapter 3 
(upper). The early portion of  this process, using an iPSC rather than an hESC, is also shown and will 
be implemented in this chapter (lower). 
Though all of  the stem cell lines are heavily dependent on FAO, this trait is not shared by 1016 
fibroblasts, which 1016 SeVA iPS cells were reprogrammed from. The FAO dependence of  the 1016 
fibroblasts is significantly reduced, according to a students’ t-test with p=0.05 (Figure 2.7). Thus, 
reprogramming alters the reliance on specific mitochondrial oxidation fuels. To study if  dependence 
also shifts during differentiation, 1016SeVA cells were cultured and differentiated into stage 1 DE 
using the protocol outlined in Figure 2.6, which is part of  a longer protocol to generate β cells from 
stem cells (Figure 4.1). Stage 1 DE cells had significantly altered dependence upon glutamine oxidation 
as determined by a students’ t-test, with p=0.05, differing from the 1016 SeVA cells even after only 
one stage of  differentiation (Figure 2.7). Thus, the dependence of  stem cells upon FAO is not a trait 
shared by all cell types, and may be a characteristic of  stem cells; this dependence also shows a shift 
even in early stages of  endodermal differentiation. 
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Figure 2.7  Reliance on fuel sources alters throughout early endodermal differentiation. Bar 
graph comparison of  the dependence of  various cell lines upon different types of  mitochondrial 
oxidation. Dependence is defined as the loss of  OCR following injection of  a small molecule. 
 
In order to provide a comparison of iPSC mitochondrial behavior to another mature cell type, we 
used a Seahorse on INS-1 cells, a rat insulinoma cell line. This cell line was also chosen because, as a 
β cell line, it provides insight into the appropriate mitochondrial behavior of a β cell. However, it is 
cancerous as well as non-human, and cancer cells tend to possess higher rates of glycolysis and lower 
rates of OXPHOS (Ganapathy-Kanniappan et al. 2013), so it may not be a representation of a healthy 
human β cell.  
 
INS-1 cells have a unique response to injection in a Seahorse run, likely due to glucose response upon 
injections, and thus cannot have a calculated dependence akin to other cell lines within this body of 
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research. However, their response to the small molecules can be quantified and compared (Figure 2.8), 
and UK5099 injection causes the greatest loss in OCR. This indicates that INS-1 cells primarily 
implement pyruvate oxidation, rather than FAO. This agrees with literature (Patterson et al. 2014). 
 
Figure 2.8  INS-1 cells rely upon pyruvate oxidation. INS-1 cells within within 2mM glucose 
media were injected with BPTES, etomoxir, or UK5099, along with glucose, resulting in a 20mM 
final concentration of glucose at the black arrow. As INS-1 cells have a glucose response, they 
cannot be analyzed similarly to the iPS cells, but relative response to etomoxir or UK5099 may be 
observed. 
 
Thus, two cell types, INS-1 and fibroblasts, were observed to have reduced dependence on FAO in 
comparison to stem cells, and there is an evident change in mitochondrial behavior besides a mere 
increase in OXPHOS and reduction in glycolysis. Additionally, as a stage 1 DE cell also possessed a 
different dependence profile, this research indicates that dependencies alter as a population 
differentiates, and that dependency may be related to cell maturity. 
Having established the mitochondrial metabolic behavior of  several cell types related to SC-β cell 
differentiation, we decided to run a Seahorse with small molecules and a functionality test on SC-β 
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cells derived using the protocol listed in Figure 2.6. The only significant change in reliance (established 
with a student’s t-test with p=0.05) on the different fuel types was a decrease in pyruvate oxidation in 
the SC-β cells. As we have not analyzed human islets, it is difficult to know if  this replicates human β 
cell behavior, though it is definitely a contrast from INS-1 cells, as it has a low reliance on pyruvate 
oxidation.  
This could be the true mitochondrial behavior of  human β-cells, but it is also possible that the SC-β 
cells are instead behaving metabolically in an immature way. In that situation, this Seahorse data has 
provided a target for further research on how to improve SC-β cell differentiation, implying that 
increasing reliance on pyruvate oxidation at baseline could improve functionality. Additionally, this 
interpretation would indicate that running a Seahorse mitochondrial functionality test with small 
molecules could also serve as a method to assess if  a SC-β cell has matured.  
 
Figure 2.9  Stem-cell derived β-cells lower reliance on pyruvate oxidation in comparison to 
iPSCs. Bar graph comparison of  the dependence of  SC-β cells and 1016 SeVA iPSCs upon different 
types of  mitochondrial oxidation. Dependence is defined as the loss of  OCR following injection of  a 
small molecule. 
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2.4.3 Analyzing the Mitochondrial Capacity of Stem Cells 
Another approach to analyzing the effect of the small molecules upon the mitochondria is quantifying 
the change in maximal respiration, the definition of which can be seen in Figure 2.2, quantifying 
maximal respiration as a fraction of the baseline OCR. Maximal respiration can indicate the capacity 
for cells to utilize certain fuel sources, which is separate from the actual usage of these fuels at baseline 
(dependence). The experimental method is identical to that implemented in Figure 2.3. To allow for 
comparison, maximal respiration is represented as a fraction of the baseline OCR (Figure 2.10). 1016 
SeVA iPS cells showed the greatest loss in maximal respiration when presented with etomoxir, 
demonstrating the cells’ capacity for FAO above other types of oxidation, a trend similar to the 
dependence of stem cells on FAO. Again, 1016 fibroblasts and stage 1 DE cells do not demonstrate 
similar capacities for the three different fuel sources, with stage 1 cells exhibiting greater capacity for 
pyruvate oxidation at maximal respiration. 
  
Figure 2.10 1016SeVA iPSCs have a greater capacity for FAO than other fuel sources. 
Maximal respiration was calculated as a fraction of the baseline OCR, with a value of one being 
equivalent to baseline, and compared between three cell lines at varying stages of maturity. Control 
here represents an injection of DMSO and the resultant maximal respiration. A statistically 
significant difference exists between the maximal respiration with etomoxir and with BPTES or the 
control, DMSO. 
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It is also significant to note that cells with different identities use different amounts of  their maximal 
capacity while sitting at baseline. Fibroblasts at baseline operate close to their maximal capacity for 
respiration, demonstrated in Figure 2.10 with the control’s maximal respiration as a fraction of  
baseline being close to one. Meanwhile, 1016 SeVA iPS cells have much unused capacity for 
respiration, with the control’s maximal respiration being approximately two times the baseline. 
Inducing a cell to tap into this unrealized respiratory capacity could also be related to differentiation.  
2.5 Conclusions 
 
Despite the tendency of a stem cell to rely upon glycolysis for ATP production, mitochondria in stem 
cells are still active, producing ATP, and appear to undergo dynamic shifts in behavior and fuel usage 
when differentiating. Using the Seahorse XF24 Extracellular Flux Analyzer, which measures OCR, we 
were able to quantify mitochondrial properties such as ATP production and maximal respiration. 
Additionally, we were able to utilize the small molecules BPTES, etomoxir, and UK5099, each of 
which resulted in a loss of OCR upon their application. Etomoxir and UK5099 inhibit the uptake of 
fatty acids and pyruvate into the cell, respectively, which inhibits FAO and pyruvate oxidation. BPTES 
inhibits glutaminase, an enzyme involved in glutamine oxidation. The loss of OCR measured upon 
each small molecule’s application is approximately equal to the OCR of the related fuel’s oxidation; 
we deemed this loss of OCR upon small molecule application to be called “dependence,” or the 
reliance of a cell upon a certain type of mitochondrial fuel oxidation. 
 
1016 SeVA iPSCs were found to rely heavily upon FAO, with it accounting for close to 75% of ATP 
production, followed by a mild reliance on pyruvate oxidation and glutamine oxidation. To confirm 
that this applied to all stem cells, and not just one line, this conclusion was confirmed in hESCs and a 
clone of the 1016 SeVA iPSCs, C9 iPSCs.  
 
As another method of analyzing the relationship of stem cell mitochondria and FAO, maximal 
respiration was quantified following application of the small molecules. Any decrease in mitochondrial 
respiration following small molecule injection, as compared to a control, represents the contribution 
of the related mitochondrial fuel oxidation. We call the maximal mitochondrial respiration that can 
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come from a certain type of fuel oxidation the “capacity.” The 1016 SeVA iPSCs demonstrated the 
greatest capacity for FAO, larger than their capacity for glutamine or pyruvate oxidation. This, 
combined with the dependence, indicates that stem cell mitochondria engage in FAO primarily when 
they’re at a resting state, and that if challenged to produce more ATP or process more fatty acids, they 
would be capable of doing so using FAO. 
 
Though this research cannot confirm exactly why this would be true, we can hypothesize. As glycolysis 
is the primary source of ATP in stem cells, it can be assumed that a large amount of pyruvate is 
produced. Some of this pyruvate is being routed to cellular respiration in the mitochondria, as 
application of the mitochondrial pyruvate transporter inhibitor UK5099 causes a drop in cellular 
respiration, but is not the most prominent source of ATP production in the cell. FAO in stem cell 
mitochondria could exist to create acetyl-CoA, which can be used as a building block in lipogenesis. 
Lipogenesis is a cytosolic process which synthesizes fats, its first step being acetyl-CoA carboxylation. 
As both pyruvate and fatty acids are converted to acetyl-CoA within the mitochondria, both can 
impact lipogenesis (Kersten 2001). A stem cell could break down fatty acids with FAO to generate 
different fats that it requires, and this has been shown to occur at a high rate in hPSCs and to be 
important for stem cell renewal and pluripotency (Zhang et al. 2016). Alternatively, the mitochondria 
could simply favor FAO over pyruvate oxidation for energy synthesis, so that pyruvate could be routed 
into fermentation and fuel further glycolysis with low oxygen consumption. The heavy dependence 
on and capacity for FAO in a stem cell could occur due to many factors, and further studies might 
reveal the precise reason for this mitochondrial behavior.  
 
Regardless of why stem cells possess a dependence on and capacity for FAO above other types of 
oxidation, this is a trait not shared to the same degree by other cell types analyzed with Seahorse. To 
prepare for characterization of endodermal differentiation to an SC-β cell, we chose to study cell types 
within this differentiation, focusing upon cells at the beginning of the process, when fibroblasts are 
reprogrammed to stem cells and those stem cells are committed to an endodermal differentiation (DE, 
stage 1 cells). 
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In fibroblasts, though FAO still accounts for the majority of ATP production, it is significantly lower 
than in iPSCs. In Stage 1 DE cells, FAO accounts for a statistically similar amount of ATP production, 
but also decreases its dependence on glutamine oxidation. 
 
To compare stem cells to an actual β-cell line, we conducted a Seahorse run on INS-1 cells, a rat 
insulinoma line. Unfortunately, these cells responded aberrantly to the mitochondrial functionality test 
we had conducted on other cell types, and to the injection of small molecules, increasing in OCR upon 
injection of many of the chemicals. We concluded that this behavior was due to a glucose response of 
the cells, which resulted in an increase in OCR. Thus, analysis of the INS-1 line was limited to injection 
of small molecules at higher concentrations, which could cancel out the glucose response and 
demonstrate dependencies upon specific fuel sources. We found that application of UK5099 resulted 
in the largest loss of OCR, indicating that a mature β-cell line relied on pyruvate oxidation over other 
types. Of course, the INS-1 line is inhuman and cancerous, which could affect its mitochondrial 
behavior and make it a flawed representation of a true human β, but overall its behavior fits with the 
narrative that is developing for the behavior of stem cells as opposed to their differentiated 
counterparts. 
 
Overall, the quantification of other cell types indicates that high reliance on and capacity for FAO, 
and low reliance on and low capacity for other types of oxidation, is characteristic of a stem cell, as 
shown by analysis with a Seahorse XF24 Extracellular Flux Analyzer. 1016 SeVA iPSC mitochondrial 
behavior and high FAO contrasts with the parent cell line they were reprogrammed from (1016 
fibroblasts), as well as mature rat insulinoma INS-1 cells and stage 1 DE cells derived from 1016 SeVA 
iPSCs. Thus, as a cell differentiates, its dependence on and capacity for certain types of oxidation will 
shift. This property could allow for control of differentiation by manipulating dependence and 
capacity for certain mitochondrial fuel types. From here on we will call the dependencies upon specific 
fuel sources, and each cell type’s capacity for use of different fuel sources, the oxidative metabolic 
profile of the cell. 
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Chapter 3 
 
Manipulation of  Mitochondrial Metabolism 
 
3.1 Abstract 
 
As we have shown that the oxidative metabolic profile may be related to cell identity and 
differentiation, it is vital to know if a researcher could easily influence this profile and thereby possibly 
influence differentiation. We show that the oxidative metabolic profile of an induced pluripotent stem 
cell can be influenced by media composition: specifically, the presence of glucose, the use of TeSR 
E8, or the small molecule etomoxir. The use of TeSR E8 and glucose starvation demonstrated the 
potential for a researcher to easily manipulate mitochondrial metabolism with media formulation, 
specifically showing that the dependence of both media alterations changed dependence, with TeSR 
E8 appearing more reliant on FAO and glucose starvation resulting in a decreased dependence on the 
three studied forms of fuel oxidation.  
 
Additionally, we demonstrated that etomoxir treated cells are capable of maintaining stem cell resting 
baseline behavior (dependence on fuel types) while undergoing changes in capacity for mitochondrial 
fuels, specifically an increase in capacity for pyruvate oxidation. To take advantage of this property 
and apply small molecules to differentiations, it is important to determine if long-term iPSC culture 
with small molecules is possible. We cultured iPSCs for multiple passages in the presence of small 
molecules impacting mitochondrial oxidation without loss of stem cell identity. This indicates that 
researchers could easily manipulate the oxidative metabolic profile of a stem cell immediately prior to 
differentiation, opening possibilities for exploring the impact of different fuel sources upon 
differentiation. 
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3.2 Materials and Methods 
 
The Seahorse mitochondrial functionality test and small molecule injection were implemented, as 
detailed in section 2.2.3 of this thesis, for study of cells in modified media. To determine if media 
formulation had an effect upon mitochondrial behavior, culture was conducted in a variety of media 
prior to Seahorse quantification; details can be seen in Table 3.1. 
Table 3.1 Modified Media Formulations 
Media Description 
TeSR E8 Simplified mTeSR1 media from STEMCELL Technologies, claims to use 
only 8 essential factors for maintaining stem cells 
Glucose-starved In the Seahorse run, the RPMI 1640 media was created without glucose. 
Cells sat within this media for 90 minutes prior to the Seahorse run. 
Etomoxir treated iPSCs were seeded in a Seahorse microplate for 48 hours, and were 
exposed to 40 μM etomoxir in mTeSR1 media during the final 24 hours 
before the media was replaced with RPMI and the Seahorse was run. 
 
For analysis of long-term culture with the small molecules BPTES, etomoxir, and UK5099, 1016 
SeVA iPSCs were single-cell dispersed and plated in 16 wells of a 24 well culture plate treated with 
fibronectin. The iPSCs were fed approximately every twenty-four hours, and after feeding the wells 
with fresh media, small molecules were added to match the final concentrations used in the Seahorse 
experiments, with 30 µM BPTES, 40 µM etomoxir, and 4 µM UK5099 at n=4 wells. Control wells 
with DMSO were also plated and treated similarly. The iPSCs were passaged by single-cell dispersal 
with TrpLE, and viability and cell count were taken with a ViCELL Cell Counter and Cell Viability 
Analyzer. During passaging, samples were saved in RNAlater from every well for later qPCR analysis. 
A pictorial depiction of this experiment is shown in Figure 3.1. 
 32 
 
 
 
 
 
 
Figure 3.1  Protocol for long-term treatment with small molecules. 1016 SeVA stem cells were 
raised in mTeSR1 in a 24 well plate, with a small molecule added (DMSO served as control), then 
passaged and seeded into a new 24 well plate. This circular protocol was repeated up to 5 times. 
 
 
3.3 Results 
 
To determine if varying media conditions could affect the oxidative metabolic profile of a iPSC, and 
thus allow a researcher to control the oxidative metabolic profile easily, 1016 SeVA iPSCs were 
cultured within a variety of media and then analyzed using the Seahorse. 
 
A mitochondrial functionality test upon the Seahorse with small molecule injection was used to analyze 
1016 SeVA iPSCs under varying media conditions. Differences in dependence upon all three studied 
fuel sources were observed; thus, differences in media formulation may impact the mitochondrial 
dependence profile of a cell line. All iPSCs remained heavily dependent upon FAO, however, which 
is understandable, as stem cell identity is maintained in TeSR E8 (Chen et al. 2011) and glucose-
starvation and etomoxir treatment are transient treatments. Even if glucose starvation and etomoxir 
treatment could induce differentiation, there would likely not be enough time to change cell identity 
during this experiment. 
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3.3.1 Media Formulation Can Alter Mitochondrial Metabolism 
1016 SeVA iPSCs raised in TeSR E8 were analyzed with a Seahorse run (Figure 3.2) and shown to 
have significantly reduced pyruvate dependence, while it had an increased dependency on FAO, 
according to a student’s t-test with p=0.05. TeSR E8 has fewer supplements than mTeSR1, and 
potentially the cells may increase FAO to support increased turnover of their fatty acid population, 
allowing generation of fats they do not have easy access to. Another explanation may be that TeSR 
E8 supports a higher degree of “stemness,” promoting higher FAO and lowering other forms of 
oxidation. 
 
 
Figure 3.2  TeSR E8 media can influence mitochondrial fuel dependencies. 1016 SeVA stem 
cells were raised within TeSR E8 media, then analyzed by injecting small molecules prior to a typical 
Seahorse mitochondrial functionality test to determine dependencies. Statistically significant 
difference from the mTeSR1 control is indicated by (*). 
 
1016 SeVA iPSCs raised in mTeSR1 were glucose starved for 90 minutes within RPMI 1640 media, 
with pyruvate added, immediately prior to a Seahorse run. We found their dependence on FAO to be 
significantly lowered, as calculated by a student’s t-test with p=0.05, indicating that other fuels were 
being oxidized (the mitochondria also oxidizes amino acids besides glutamine, for example). This 
effect could also be a sign of cell distress or death; as stem cells are reliant upon glycolysis to provide 
their ATP production, an absence of it could significantly stress iPSCs.  
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Figure 3.3  Glucose starvation can influence mitochondrial dependence on FAO. 1016 SeVA 
stem cells were raised within mTeSR1 media, and in the 90 minute period where we applied RPMI 
1640 and pyruvate were exposed to a glucose-free environment. Then, the cells were analyzed by 
injecting small molecules prior to a typical Seahorse mitochondrial functionality test to determine 
dependencies. Statistically significant difference from the 20mM control is indicated by (*). 
1016 SeVA iPSCs raised in mTeSR1 were treated with etomoxir for 24 hours prior to the start of  a 
Seahorse run, which revealed a significant increase in FAO dependency following a brief  recovery 
period (Figure 3.4). This recovery period occurred when etomoxir was removed from the cells for 1.5 
hours prior to the start of  the Seahorse run. As the dependency on FAO increased following this 
treatment, it is possible that the iPSCs were attempting to recover, following culture where they had 
reduced fatty acid transport into the mitochondria. 
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Figure 3.4  Etomoxir treatment increases reliance on FAO after brief recovery period. 1016 
SeVA stem cells were raised within mTeSR1 media, and in the 24 hours before the Seahorse run 
were exposed to etomoxir. Then, the cells were analyzed by injecting small molecules prior to a 
typical Seahorse mitochondrial functionality test to determine dependencies. Statistically significant 
difference from the 20mM control is indicated by (*). 
 
As can be seen, etomoxir’s effect on the resting behavior of a stem cell seems to alter only FAO. 
However, maximal respiration can also be analyzed as a fraction of the baseline OCR (Figure 3.5). We 
found that the impact of UK5099 upon maximal respiration increased significantly following 24 hours 
of etomoxir treatment, as determined by a student t-test between the two conditions with p=0.05. 
This indicates that although baseline behavior remains unchanged, it is possible to alter stem cell 
capacity for a specific fuel source. It is possible that this somewhat consistent baseline behavior, 
coupled with a change in capacity, could indicate that the stem cells are still behaving similarly to stem 
cells at baseline, with high FAO, but could be ‘primed’ to behave differently, especially if they were to 
undergo differentiation.  
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Figure 3.5  Etomoxir treatment increases capacity for pyruvate oxidation. 1016 SeVA stem 
cells were raised within mTeSR1 media, and in the 24 hours before the Seahorse run were exposed 
to etomoxir. Then, the cells were analyzed by injecting small molecules prior to a typical Seahorse 
mitochondrial functionality test to determine capacity. 
 
3.3.2 Long-Term Treatment with Small Molecules Is Plausible 
Having established that treatment with small molecules can impact the mitochondrial metabolism of 
stem cells, it is important to discern if this treatment can be applied to differentiation. Applying small 
molecules to iPSC culture over a period of days prior to a differentiation, long-term, might allow for 
alteration of their mitochondrial metabolism, and in extension their differentiation. To ascertain the 
plausibility of long-term culture with the three small molecules impacting mitochondrial fuel usage—
BPTES, etomoxir, and UK5099— 1016 SeVA iPSCs were raised in mTeSR1 with addition of the 
small molecules. These stem cells were capable of retaining essential stem cell gene expression for up 
to five passages with the small molecules, as shown through the maintenance of the OCT4 and 
NANOG genes (Figure 3.6), which are related to stem cell self-renewal and proliferation, respectively. 
Statistically, there was no significant difference between the expression of these genes between the 
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conditions. UCP2, which encodes uncoupling protein 2 and serves to separate ATP synthase and the 
electron transport chain, was also measured and found to be maintained throughout five passages. 
 
Figure 3.6 Small molecule treated iPSCs retain stem cell relative gene expression.  1016 
SeVA iPSCs were maintained within a 24 well plate with 30 µM BPTES, 40 µM etomoxir, or 4 µM 
UK5099 for up to 5 passages. Samples were collected upon passaging and analyzed with qPCR for 
relevant stem cell genes. 
 
While expression of important stem cell genes were maintained, morphology was also retained. Small 
molecule treated cells were capable of reaching confluency (Figure 3.7) with minimal visible 
differences between their cell morphologies and that of the control wells. Retaining the ability to grow 
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to confluency and keep growth rate serves not just as an indicator of stemness, but also as an essential 
component of being able to proceed effectively through differentiation, producing a large enough 
quantity of treated cells to proceed through the differentiation process and be implanted. Notably, 
brown debris is visible in the BPTES wells; possibly hydrophobic BPTES falling out of solution. 
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Figure 3.7 Culture with small molecules does not alter cell morphology or confluency.  1016 
SeVA iPSCs were maintained within a 24 well plate with 30 µM BPTES, 40 µM etomoxir, or 4 µM 
UK5099 for up to 5 passages, and pictures at two different magnitudes (5X above, 10X below) were 
taken, demonstrating no apparent change in morphology or ability to reach confluency. 
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Despite retaining the ability to reach confluency and maintain cell morphology, a loss of  cell viability 
was observed in later passages, and growth rate was slightly altered (Figure 3.8). Cell death appears to 
peak during passage 3, and cell count was lowest during passage 2 and 3, but both issues began to 
resolve as cells approached passage 5. These negative effects would not be enough to prevent long-
term use of  these small molecules upon an iPSC population. This raises the possibility that iPSCs 
could be treated with BPTES, etomoxir, or UK5099 prior to a differentiation in the long-term. 
 
 
Figure 3.8 iPSCs treated with small molecules retain acceptable viability and growth rate. 
1016 stem cells were raised under small molecules impacting mitochondrial function, demonstrating 
minor loss in viability and growth rate. 
 
3.4 Conclusions 
 
As established in Chapter 1, stem cells start with a reliance on and capacity for FAO and appear to 
undergo shifts in mitochondrial behavior throughout differentiation, resulting in alteration of 
dependence and capacity for certain types of mitochondrial oxidation. Control or manipulation of this 
shift in oxidation could allow a researcher to influence differentiation. We showed that alterations in 
media formulation were capable of altering dependence upon fuel sources.  
 
Specifically, cells raised in TeSR E8 relied even more heavily upon FAO, indicating a possible increase 
in stemness or requirement for lipogenesis. Stem cells that were glucose starved demonstrated a 
decrease in oxidation of FAO, which could be the result of an increase in usage of other fuels or a 
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result of cell stress. Stem cells cultured with etomoxir demonstrated an increased dependence on FAO 
after they had 90 minutes to recover, but overall fairly unchanged dependences upon the different 
types of mitochondrial oxidation. However, there was a drastic increase in capacity for pyruvate 
oxidation, indicating that while resting cell behavior remained unaltered the mitochondria changed 
their ability to utilize pyruvate oxidation and FAO. This change in capacity could possibly influence 
future differentiation of a stem cell while still maintaining the baseline behavior characteristic of a 
stem cell, allowing a researcher to impact differentiation but not induce premature, uncontrolled 
differentiation.  
 
Thus, a change in overall media formulation, a deprivation of one of the three studied fuels, and 
treatment with a small molecule were all possible and altered the mitochondrial metabolic profile of 
1016 SeVA iPSCs. This opens up the possibility for future research into media formulations, fuel 
deprivation, or small molecule treatment. Knowing that manipulation of the oxidative metabolic 
profile is possible with the studied small molecules, it was imperative to determine if long-term 
treatment with etomoxir and the other small molecules was possible. Long-term treatment would 
allow manipulation of the stem cell population in preparation for a differentiation. 
 
To study whether mitochondrial metabolism manipulation with small molecules prior to a 
differentiation would be possible, we conducted long-term culture with small molecules impacting 
three types of mitochondrial oxidation. We showed that 1016 SeVA stem cells could be cultured long-
term with the small molecules BPTES, etomoxir, and UK5099, which inhibit glutamine, fatty acid, 
and pyruvate oxidation, respectively. This extended culture did result in lower cell viability and cell 
count, but not to a degree which made it difficult to culture them, or where there was massive cell 
death (typically viability remained above 85%). Their morphologies and ability to reach confluency 
also did not change, in total making it plausible for a researcher to use the small molecules in long-
term culture. Ultimately, the treatment did not affect gene expression of stem cell markers from the 
control, indicating that the iPSCs had retained their pluripotency and self-renewal and were capable 
of differentiation. This implies that iPSCs can be cultured with small molecules in the long-term, while 
maintaining their identity as a stem cell, and allowing for possible influence on differentiation. 
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Thus, this body of work provides a researcher with easy, accessible tools to influence mitochondrial 
behavior in a stem cell by altering media components, which could potentially be incorporated with 
differentiation protocols to help optimize them. 
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Chapter 4 
 
Mitochondrial Metabolism and SC-β Cell 
Differentiation 
 
4.1 Abstract 
 
While it is known that mitochondrial respiration, network formation, and possibly biomass change as 
an iPSC differentiates, it is vital to this research to know if mitochondrial uptake and usage of fuels 
alters as an iPSC differentiates. We discovered that mitochondrial uptake and likely mitochondrial 
metabolism shifts drastically but in a consistent pattern during endodermal differentiation to an SC-β 
cell, as tracked by gene expression of relevant mitochondrial oxidation genes. This indicates that 
alteration of mitochondrial oxidation and oxidation fuel sources could impact differentiation. We also 
discovered, in agreement with the literature established conclusion that mature cells tend to require 
more OXPHOS and mitochondrial activity than a stem cell, that relative gene expression of 
mitochondrial fuel transporters increased within SC-β cells. 
 
To utilize this discovery that mitochondrial uptake of certain fuels alters through differentiation, we 
applied the small molecules BPTES, etomoxir, and UK5099 to an SC-β cell differentiation during 
transition to stage 1 DE cells.  We conducted several differentiations (both adherent and in 
suspension) implementing these small molecules during this transition, taking samples at stage 1 and 
assessing definitive endoderm markers, and stopping the differentiation at stage 4 (pancreatic 
progenitors) to predict the potential for a full SC-β differentiation (Pagliuca et al. 2014). The stage 1 
DE cells showed increases in DE markers with small molecule treatment, indicating improved 
differentiation. However, in stage 4 cells, the small molecule treatment resulted in no change from the 
control in relative gene expression at stage 4 for any of the small molecule treatments, indicating that 
addition of small molecules in those conditions did not improve the differentiation process. However, 
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this experimentation demonstrated the possibility of adding the small molecules BPTES, etomoxir, 
and UK5099 without halting or damaging endodermal differentiation in both adherent and suspension 
culture.  
 
Thus, we’ve established that mitochondrial genes alter with differentiation and likely influence it, as 
well as indicating that a researcher could use the studied small molecules and implement them in 
differentiation to try and optimize the process, a useful tool. 
4.2 Materials and Methods 
 
A human embryonic stem cell line (HUES8) underwent endodermal differentiation in suspension 
culture, designed to generate glucose responsive, insulin producing stem-cell derived β-cells (Pagliuca 
et al., 2014) in six stages (Figure 4.1). This procedure has been modified since its initial design in 2014 
within the Millman lab to increase glucose responsiveness, insulin production, and β-cell markers of 
the generated cells. 
 
Figure 4.1 Differentiation protocol for a stem-cell derived β-cell. The listed factors and duration 
of the time steps can read about in detail in Pagliuca et al., 2014. 
 
At every conclusion of a differentiation stage— barring stage 2, primitive gut tube (PGT)—samples 
were collected and stored in RNAlater. RNA was extracted, cDNA synthesized, and qPCR conducted 
upon the samples. Three separate differentiations were analyzed. To confirm a successful 
differentiation, stage 1, stage 4, and stage 6 gene markers were studied (Figure 4.2).  
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Figure 4.2 Expected appearance of differentiation markers for a stem-cell derived β-cell.  
 
The related proteins and functions of these differentiation markers can be seen in Table 4.1. Two 
other differentiation markers, which will only be used to assess stage 1, are also shown. 
Table 4.1 Differentiation marker gene summary 
Gene Protein and function 
OCT4 Involved in embryonic stem cell self-
renewal. 
FOXA2 Encodes a transcription factor essential for 
β cell development (Lee 2005). 
PDX1 Encodes a transcription factor essential for 
β cell development 
INS Encodes the hormone insulin, which is 
produced by β cells 
GSC Encodes a transcription factor, a definitive 
endoderm marker (McLean et al. 2007). 
CER1 Encodes a transcription factor, a definitive 
endoderm marker (McLean et al. 2007). 
 
Other genes included in the qPCR run were related to transport of fuel into the mitochondria, as 
detailed in Table 4.2. 
 
 
 
 
 
 
 46 
 
 
 
 
 
Table 4.2 Mitochondrial metabolism gene summary 
Gene Protein and function Related Oxidation Pathway 
GLS Glutaminase, an enzyme that catalyzes the 
conversion of glutamine to glutamate 
Glutamine oxidation 
CPT1A Carnitine palmitoyltransferase I, transports 
long-chain fatty acids into the mitochondria 
FAO 
MPC1 Mitochondrial pyruvate carrier 1, transports 
pyruvate into the mitochondria 
Pyruvate oxidation 
MPC2 Mitochondrial pyruvate carrier 2, transports 
pyruvate into the mitochondria 
Pyruvate oxidation 
To test the potential for use of  the small molecules during differentiation, an endodermal 
differentiation to SC-β cells was conducted with small molecules applied during the first phase of  
treatment to reach DE, or stage 1. This differentiation was conducted within 6 well plates with both 
adherent and suspension ESCs. The small molecules were not applied at any other time during the 
differentiation other than prior to reaching stage 1. The differentiation was halted once the cell 
population reached stage 4, and samples were collected and stored in RNAlater. RNA was extracted, 
cDNA synthesized, and qPCR was conducted to test for the endodermal stage 4 markers, PDX-1 and 
NKX6-1. 
4.3 Results 
 
4.3.1 Relative Gene Expression of Mitochondrial Transport Genes 
Displayed Trends Throughout SC-β Differentiation 
 
In order to characterize the mitochondrial uptake of fuel sources throughout a differentiation, we 
analyzed RNA samples taken at each stage of an SC-β cell differentiation with qPCR, studying the 
relative gene expression of mitochondrial transport proteins, genes involved in glutamine oxidation, 
and genes involved in SC-β cell differentiation. 
 
The RNA samples of each differentiation stage were analyzed by qPCR, studying genes related to 
transport of pyruvate and fatty acids into the mitochondria, or the gene related to glutaminase, an 
essential enzyme in glutamine oxidation. The temporal relative gene expression showed trends 
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throughout differentiation for all genes analyzed, with significant differences from iPS cells and, for 
many, from Stage 4 pancreatic progenitor cells, showing fluctuations (Figure 4.3). All significances 
were determined by a student’s t-test with a p=0.05. The mitochondrial transporter genes GLS, MPC1, 
MPC2, and CPT1A all showed a significant increase in expression from iPSCs, indicating a likelihood 
that mitochondrial fuel uptake increases in SC-β cells. This indicates that a variation in expression of 
these transport proteins or enzymes, and possibly a change in uptake of their respective fuel sources, 
is likely related to successful differentiation. UCP2, which has previously been implicated in stunting 
human embryonic stem cell mitochondrial oxidation (Zhang et al. 2011) and decreasing upon 
differentiation, stayed relatively constant, increasing significantly in the final stages of differentiation.  
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Figure 4.3 Mitochondrial gene expression correlates to differentiation stage. Average gene 
expression throughout several endodermal differentiations to an SC-β cell, with n=3 or 4. Those 
marked with a black (*) represent relative gene expression significantly different from iPS cells and 
from stage 4 cells, while those marked with a green (*) are significantly different from stage 4 cells. 
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To confirm that these findings were made with successful differentiations, several differentiation 
marker genes were analyzed using qPCR (Figure 4.4). These markers showed gene expression 
correlating to the expected gene expression shown in Figure 4.2. OCT4, a stem cell marker, expressed 
only prior to stage 1. FOXA2, which is intended to express initially in stage 1 of an endodermal 
differentiation, showed high expression in stage 1 and onwards. PDX1, which is known to begin 
expressing in stage 3 or 4, appeared as expected in the differentiation. Finally, INS was generated in 
all of the experiments, expressing in stage 5, a strong indicator of whether an SC-β cell has been 
generated. Thus, the differentiations analyzed for mitochondrial transport genes were valid 
differentiations that resulted in pancreatic progenitor cells, expressing appropriate pancreatic lineage 
genes. 
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Figure 4.4 Differentiations successfully generated pancreatic progenitors, with expected 
temporal gene expression. Gene expression analysis to confirm a successful endodermal 
differentiation, showing high relative gene expression of appropriate markers. 
-0.25
0
0.25
0.5
0.75
1
iPS St1 St3 St4 St5 St6
OCT4
0
3
6
9
12
iPS St1 St3 St4 St5 St6
FOXA2
0
1
2
3
4
iPS St1 St3 St4 St5 St6
PDX1
0
2
4
6
8
iPS St1 St3 St4 St5 St6
R
el
at
iv
e 
G
en
e 
Ex
p
re
ss
io
n
Differentiation Stage
INS
 51 
 
 
 
 
 
4.3.2 Small Molecule Treated Cells Demonstrate Potential 
Improvement of SC-β Cell Differentiation 
Having characterized relative gene expression of  mitochondrial oxidation related genes, it was 
important to attempt to apply the results to an actual differentiation and manipulate it. The small 
molecules BPTES, etomoxir, and UK5099 were applied during the transition to Stage 1 DE cells, but 
otherwise differentiation was conducted with the same SC-β cell protocol as used in 4.3.1. 
An endodermal differentiation to SC-β cells was conducted in both suspension and adherent cell 
populations, and samples were taken at stage 1 (DE) for qPCR analysis to determine how stage 1 
marker gene expression was affected (Figure 4.5). Expression of  certain genes involved in embryonic 
development significantly increased in small molecule treated cells, indicating possible improvement 
of  SC-β cell differentiation. 
 
Figure 4.5 Small molecule treatment improves expression of embryonic development genes 
in SC-β differentiation. Gene expression analysis confirmed significantly increased expression of 
GSC and CER1 in cells having undergone SC-β cell differentiation to stage 1. (*) indicates significant 
difference from DMSO relative gene expression by a student’s t-test. 
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The same endodermal differentiation to SC-β cells was conducted in both suspension and adherent 
cell populations, and halted at stage 4 to assess pancreatic progenitor potential to become a stem cell 
derived β cell; qPCR was used to analyze samples taken from the stage 4 cells to assess for successful 
differentiation by expression of  stage 4 markers. The stage 4 markers were present, and similar to a 
DMSO control within suspension and some adherent cells, although UK5099 application appeared to 
cause lowering of  the stage 4 markers within the adherent cells. This indicates that the inclusion of  
small molecules in media during differentiation for both suspension and adherent culture is plausible 
(Figure 4.6). Notably, BPTES was not included within adherent culture; this was for reducing cost, as 
early differentiations with BPTES did not show much promise for endodermal differentiation. 
 
Figure 4.6 Endodermal differentiation is possible in the presence of small molecules. Gene 
expression analysis confirmed expression of NKX6-1 and PDX1 in cells having undergone SC-β cell 
differentiation to stage 4. 
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4.4 Conclusions 
 
The previous chapters demonstrated that the mitochondrial metabolism and reliance of the 
mitochondria upon different fuel sources altered with cell identity, particularly within an endodermal 
differentiation, and that this mitochondrial metabolism could be controlled by a researcher using 
media formulations. Following these discoveries, it was important to characterize and potentially 
manipulate an endodermal differentiation. As the Millman lab specializes in the differentiation of SC-
β cells, this differentiation protocol was chosen (Pagliuca et al., 2014). 
 
Several differentiations were conducted, RNA was collected, and qPCR was used to analyze relative 
gene expressions. Notably, all differentiations studied and sampled demonstrated appropriate relative 
gene expression of stem cell markers, pancreatic progenitor markers, and SC-β cell markers, like INS. 
This serves as confirmation that the differentiations studied were valid SC-β cell differentiations, and 
their results are representative of the differentiation process. 
 
We showed that relative gene expression of mitochondrial transport proteins related to oxidative 
phosphorylation followed trends throughout differentiation to a SC-β cell. In particular, the genes 
CPT1A, MPC1, and MPC2, all encoding mitochondrial fuel transporters, appeared to follow a pattern 
within differentiation. The relative gene expression of these transporters increased during the final 
stage of differentiation to an SC-β cell, implying that they might support greater quantities of FAO 
and pyruvate oxidation by allowing the mitochondria to uptake larger amounts of food molecules. We 
would expect cells which are more mature and rely on mitochondrial energy production, rather than 
glycolysis, to utilize pyruvate oxidation and FAO to a greater degree, allowing the relative gene 
expression results to be reasonable. 
  
Despite transport genes’ relative expression increasing during the final stage of differentiation (SC-β 
cells), their expression throughout the process of differentiation did not show a steady upward trend. 
Instead, relative gene expression lowered and rose throughout the differentiation protocol. This was 
not random; the fluctuations were consistent between several different experiments. These results 
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indicate that uptake of mitochondrial fuel sources could impact differentiation, or are at least closely 
related to the process. 
 
The gene GLS, which encodes the enzyme glutaminase involved in glutamine oxidation, did not 
demonstrate any patterns throughout differentiation. It is possible that glutamine oxidation is not as 
vital to differentiation as FAO or pyruvate oxidation, or that the enzyme’s expression alone is not 
representative of glutamine oxidation. Further research into glutamine oxidation could be important, 
but this study has revealed little of interest. 
 
Having characterized several genes directly related to the three studied types of mitochondrial 
oxidation, and having established the importance of mitochondrial fuel uptake for endodermal 
differentiation to a SC-β cell, we decided to attempt to disrupt mitochondrial fuel uptake within an 
SC-β cell differentiation by using the small molecules BPTES, etomoxir, and UK5099. 
 
SC-β cell differentiation was conducted in both suspension and planar culture, with the small 
molecules BPTES, etomoxir, and UK5099 applied during the first step of differentiation to a DE 
(stage 1) cell. We took samples upon the cells reaching stage 1 (DE) and conducted qPCR, finding 
that the relative gene expression of embryonic development genes CER1 and GSC were increased 
significantly in small molecule treated cells in comparison to the DMSO control. This indicates that 
treatment with small molecules could possibly improve differentiation; this is especially significant 
because the differentiation of DEs is already effective, and thus any improvement is especially 
interesting. 
 
We halted the differentiation once the cells reached stage 4, pancreatic progenitor 2 (PP2) cells, as 
differentiation to stages 5 and 6 can be expensive and result in a more inhomogeneous cell population, 
which could skew results (Pagliuca et al., 2014). During this stage, it’s possible to assess the potential 
of the cells to become functional SC-β cells by analyzing relative gene expression of PDX-1 and 
NKX6-1, both of which are endodermal lineage markers that should express during stage 4, PP2. In 
our differentiations, those treated by small molecules and those treated as a control (DMSO) showed 
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appropriate gene expression of PDX-1 and NKX6-1, and were assessed to have good potential for 
further differentiation to a functional SC-β cell. 
 
Though this reserach did not demonstrate a benefit from application of small molecules during 
transition to stage 1 (definitive endoderm), it did demonstrate that SC-β cell differentiation with small 
molecules applied was possible, and allowed differentiation. This is vital information to any researcher 
hoping to continue this work and apply any of the studied small molecules to a differentiation. 
 
As a side note, UCP2 relative gene expression was also studied and characterized within SC-β cell 
differentiation. Previous work with hPSCs has implicated UCP2 as a metabolism regulator, ensuring 
glycolysis produces much of the cell’s ATP, and indicating that it should reduce in expression upon 
differentiation (Zhang et al. 2011). These conclusions were contradicted directly by this work, as UCP2 
levels were maintained or increased. This could lead to three possible conclusions: the literature 
findings do not apply to endodermal differentiation to an SC-β cell (this is plausible, as cardiomyocytes 
and fibroblasts were tested), the assertion that UCP2 is high in stem cells but lowers upon 
differentiation is false, or the SC-β cells produced in our lab are flawed and have the potential for 
improvement if UCP2 is altered. While we’re not certain which of these conclusions is true, there has 
been work done with SC-β cell differentiation that implies that lowering UCP2 could lead to better 
functionality and maturity of an SC-β cell (Pezzolla et al. 2015), which supports our results and serves 
as a lead for our lab in further optimization of SC-β cell differentiation. Regardless, UCP2 is a 
mitochondrial membrane protein, which emphasizes the importance of mitochondrial function during 
differentiation regardless of the type of fuel uptake. 
 
In conclusion, mitochondrial uptake of specific fuels was shown to be related to the process of SC-β 
cell differentiation, we showed that small molecule treatment could improve differentiation to stage 1 
DE cells, and we demonstrated that it was possible to run a differentiation with small molecules that 
impacted fuel uptake. 
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4.5 Future Directions and Final Conclusions 
 
Though much literature on stem cell behavior and metabolism has focused upon the relationship 
between glycolysis and the mitochondria as the source of ATP synthesis, we assert that the 
mitochondria is still partially active in stem cells, and that its behavior can impact differentiation. 
Though the high rate of glycolysis generates much pyruvate, we found that stem cell mitochondria 
mainly processes fatty acids. Stem cells were found to rely heavily on mitochondrial FAO, and to have 
a great capacity for it, a trait that differed from other cell types and from cells that have committed to 
a lineage. Though we could not confirm the underlying reason for this trait, we can reasonably 
hypothesize that the oxidative mitochondrial metabolism favoring FAO over pyruvate oxidation could 
be the result of pyruvate undergoing fermentation to fuel further glycolysis rather than undergoing 
OXPHOS, or hypothesize that stem cells require extensive lipogenesis for self-renewal (Zhang et al. 
2016) and pluripotency and thus conduct FAO for its support. 
 
Having established that oxidative mitochondrial metabolism alters with differentiation, we moved to 
providing a toolset for a future researcher to use in study of this phenomenon. This work has set the 
foundation for future research into manipulation of differentiation, particularly SC-β cell endodermal 
differentiation, through manipulation of the oxidative metabolic profile, which we have defined as 
reliance upon and capacity for certain types of oxidation. Alteration of media composition, availability 
of food molecules like glucose, and application of small molecules were all shown to be simple, easily 
accessible, and effective methods of altering the oxidative metabolic profile. 
 
From establishing the possibility of easy manipulation of oxidative metabolic profile, we moved on to 
quantifying and influencing actual SC-β cell differentiation. We determined that, in effective 
differentiations, the relative gene expression of specific mitochondrial transporter genes followed 
patterns throughout the endodermal differentiation process. This promoted our idea that pyruvate 
oxidation and FAO are heavily correlated with the process of differentiation. Unfortunately, our 
preliminary attempts to manipulate the oxidative metabolic profile with small molecules did not result 
in improvement of differentiation, as measured by relative gene expression of PDX-1 and NKX6-1 
within pancreatic progenitor stage 4 cells. These attempts did prove the possibility of a successful 
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differentiation even with small molecule treatment within both adherent and suspension culture 
systems.  
 
While literature has established that mitochondrial behavior alters with differentiation and could 
possibly control it, a characterizable change in mitochondrial behavior aside from morphology, general 
activity levels, and biomass (which is debatable) has not been presented. We believe this research 
supports the idea that mitochondrial uptake and oxidation of specific fuel types serves as the 
mechanism of mitochondrial change with differentiation. 
 
If the work conducted here could serve as a basis for further research on SC-β cell differentiation, and 
result in an improvement or optimization of the process, that would fulfill the goal of this research. 
This would presumably be accomplished by manipulation of cell dependence and capacity throughout 
the differentiation process, encouraging the mitochondrial behavior to alter to that of a mature cell 
type and thus encouraging successful, efficient differentiation. Ideally, in continuation of the study of 
SC-β cell endodermal differentiation, cadaveric islets would undergo a Seahorse test. As it is, cadaveric 
β-cells are expensive, and as the glucose response of the INS-1 insulinoma cell line has prevented 
proper study of it, our group hesitated to invest the resources in a cadaveric β-cell Seahorse run at this 
time. However, further study of differentiation and the relative gene expression of various genes 
related to mitochondrial metabolism could be significant, and creating a relative expression profile for 
many mitochondrial genes across a differentiation would be beneficial.  
 
Future research on this topic would investigate oxidative metabolic profile and gene expression 
throughout differentiation to other germ layers, and to other cell types, to determine the importance 
of mitochondrial OXPHOS and fuel sources in other differentiation protocols. This would establish 
the importance of mitochondrial metabolism and oxidation in the stem cell and its differentiation to 
any somatic cell. 
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